Gossamer Bio Inc (GOSS) — Financial Flexibility Index
Gossamer Bio Inc (GOSS) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of $-36.17 Million (operating CF $-36.17 Million minus capex $0.00) represents 0% of total liabilities ($291.15 Million). Check GOSS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gossamer Bio Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Gossamer Bio Inc across 9 annual periods. For the full cash flow conversion analysis, see GOSS cash generation efficiency.
Annual Financial Flexibility Index for Gossamer Bio Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Gossamer Bio Inc. Explore GOSS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.01x | $-3.47 Million | $-3.47 Million | $285.80 Million | ▲ +98.1% |
| 2023 | -0.64x | $-159.16 Million | $-159.16 Million | $249.15 Million | ▲ +10.8% |
| 2022 | -0.72x | $-186.56 Million | $-187.03 Million | $260.37 Million | ▲ +15.0% |
| 2021 | -0.84x | $-187.27 Million | $-188.89 Million | $222.19 Million | ▼ -21.7% |
| 2020 | -0.69x | $-151.48 Million | $-176.36 Million | $218.75 Million | ▲ +62.9% |
| 2019 | -1.87x | $-138.27 Million | $-144.83 Million | $74.12 Million | ▼ -2147.9% |
| 2018 | -0.08x | $-29.83 Million | $-51.04 Million | $359.49 Million | ▲ +73.1% |
| 2017 | -0.31x | $-2.25 Million | $-5.75 Million | $7.31 Million | ▼ -101.6% |
| 2016 | 19.18x | $3.51 Million | $20.00K | $183.00K | — |